Laboratory Animal and Comparative Medicine ›› 2022, Vol. 42 ›› Issue (3): 171-176.DOI: 10.12300/j.issn.1674-5817.2022.073

• Review of Frontier Literature •     Next Articles

The Latest Research Progress of the Function of Spinal CD11c+ Microglia in Neuropathic Pain

Changgeng PENG1()(), Yan FU1,2(), Fengting ZHU1,3(), Ruilong XIA1, Wei XIA1   

  1. 1.First Rehabilitation Hospital of Shanghai, School of Medicine, Advanced Institute of Translational Medicine, Tongji University, Shanghai 200092, China
    2.College of Fisheries and Life Science, Shanghai Ocean University, Shanghai 201306, China
    3.School of Basic Medical Sciences, Dali University, Dali 671000, China
  • Received:2022-05-23 Revised:2022-06-17 Online:2022-06-25 Published:2022-07-01
  • Contact: Changgeng PENG

Abstract:

Neuropathic pain (NP) affects approximately 10% of the population, and treatments and drugs for NP have limited efficacy. Microglia in the spinal cord play important and paradoxical roles in peripheral nerve injury-induced NP, both promoting the development of NP and relieving NP. In April 2022, Keita Kohno et al. reported that after peripheral nerve injury, CD11c+ microglia appearing in the spinal cord of mice were a type of microglia that relieve NP and inhibited pain recurrence. In this commentary, we review the important findings of this type of analgesic microglia subset, and provide a perspective for future work related to this new finding.

Key words: Neuropathic pain, Microglia, CD11c, IGF1, Analgesic, Anti-inflammatory, Mice

CLC Number: